Chianelli, M;
Busetto, L;
Vettor, R;
Annibale, B;
Paoletta, A;
Papini, E;
Albanese, A;
Carabotti, M;
Casarotto, D;
De Pergola, G;
Disoteo, O E;
Grandone, I;
Medea, G;
Nisoli, E;
Raffaelli, M;
Schiff, S;
Vignati, F;
Cinquini, M;
Gonzalez-Lorenzo, M;
Fittipaldo, V A;
Minozzi, S;
Monteforte, M;
Tralongo, A C;
Novizio, R;
Persichetti, A;
Samperi, I;
Scoppola, A;
Borretta, G;
Carruba, M;
Carbonelli, M G;
De Luca, M;
Frontoni, S;
Corradini, S. G;
Muratori, F;
Attanasio, R.
This guideline (GL) is aimed at providing a clinical practice reference for the management of adult patients with overweight or obesity associated with metabolic complications who are resistant to lifestyle modification.
Surgeons, endocrinologists, gastroenterologists, psychologists, pharmacologists, a g...
Pharmacological management of obesity improves outcomes and decreases the risk of obesity-related complications. This American Gastroenterological Association guideline is intended to support practitioners in decisions about pharmacological interventions for overweight and obesity. A multidisciplinary pa...
Pharmacological treatments are an effective and scalable approach to treating obesity. As with any chronic disease, such as type 2 diabetes (T2DM) or hypertension, pharmacotherapy is an important pillar in the management of obesity.
The focus of obesity management should be the improvement of health para...
Primary care clinicians should initiate patient-centred conversations with their patients about overweight or obesity. The 5As of Obesity ManagementTM (Ask-Assess-Advise-Agree-Assist) approach, starting with asking permission to discuss weight, is an appropriate format to use.
Primary care clinicians sho...
The commercial weight loss industry is enormous. Clinicians should familiarize themselves with the commercial obesity management offerings in their vicinity. Criteria have been published to evaluate whether a commercial program is safe and potentially successful (i.e., offering a combination of nutriti...
